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666HIGHLIGHTS
 A drop in eosinophil blood count is associated with recruitment of eosinophils to the heart during repair
following clinical and experimental MI.
 Genetic and pharmacological eosinophil depletion leads to increased adverse remodeling in
experimental MI.
 Eosinophils are required for acquisition of an anti-inflammatory macrophage phenotype, a shift to resolution of
inflammation and mature scar formation during infarct repair.
 IL-4 therapy is able to rescue the adverse remodeling phenotype in conditions of eosinophil deficiency.SUMMARYIn ST-segment elevation myocardial infarction of both patients and mice, there was a decline in blood eosinophil count,
with activated eosinophils recruited to the infarct zone. Eosinophil deficiency resulted in attenuated anti-inflammatory
macrophage polarization, enhanced myocardial inflammation, increased scar size, and deterioration of myocardial
structure and function. Adverse cardiac remodeling in the setting of eosinophil deficiency was prevented by interleukin-4
therapy. (J Am Coll Cardiol Basic Trans Science 2020;5:665–81) © 2020 The Authors. Published by Elsevier
on behalf of the American College of Cardiology Foundation. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).M yocardial infarction (MI) occurs mostcommonly following acute thrombotic oc-clusion of a coronary artery, and triggers
an acute inflammatory response. Within hours, neu-
trophils are recruited to the infarcted myocardium
followed by infiltration of proinflammatory mono-
cytes (1). Acquisition of a proresolution proliferative
macrophage phenotype is critical to successful infarct
repair (2). Failure to expand the number of CD206þ
proresolution macrophages following MI is associated
with increased cardiac rupture and adverse cardiac
remodeling because of disrupted collagen fibril for-
mation during infarct healing (2). Interventions that
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Macrophage phenotype can be determined by
environmental factors and importantly by cells of the
innate and adaptive immune system, including eo-
sinophils. Tissue eosinophilia is commonly associated
with helminth infection, allergy, and gastrointestinal
disorders. In these settings, eosinophils are effector
cells with proinflammatory and destructive capabil-
ities through the secretion of cytotoxic granules,
cationic proteins, and proteolytic enzymes (4). How-
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FIGURE 1 Blood Eosinophil Count Is Reduced, Independently of Changes in Neutrophil Count in ST-Segment Elevation Myocardial Infarction Patients,
While Eosinophils Accumulate in the Human Heart Following MI
(A) Peripheral blood eosinophil count and (B) neutrophil count in patients with stable angina (SA) or at time from onset of chest pain in patients with ST-segment
elevation myocardial infarction (MI). *p < 0.05 relative to patients with SA. SA patients: n ¼ 307; ST-elevation MI patients: n ¼ 732. (C, D) Eosinophil peroxidase
immunopositive eosinophils were located in within the infarct zone of human postmortem hearts (typical of n ¼ 4), (E, F) distribution was sparse in comparison to Gr-1
immunopositive neutrophils identified in the same samples. (C, inset) A negative control section stained with an IgG of the same class as the EPX antibody.
eo ¼ eosinophil; ne ¼ neutrophil.
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667in the resolution of inflammation (4). Previous
studies have linked peripheral blood eosinophil count
MI to short-term risk of mortality in low- to inter-
mediate-risk patients (5) and high-risk patients (6,7)
following myocardial infarction. However, whether
eosinophils have any role in repair of the adult
mammalian heart is so far unknown.
The primary goal of the present study was to
address the role of eosinophils in repair of the heart
following MI in the setting of patients with acute ST-
segment elevation MI (STEMI) and in an experimental
model of MI in mice with genetic (DdblGATA) (8) or
pharmacologic depletion of eosinophils.
METHODS
PATIENT SELECTION WITH STEMI. All patients
included in the STEMI registry were $18 years of age,
had chest pain of <12 h duration, and had persistentST-segment elevation in at least 2 contiguous leads of
the electrocardiogram (9). Patients with a history of
stable angina undergoing elective percutaneous cor-
onary intervention were used as the control group.
This study was reviewed and approved by the Essex
Cardiothoracic Centre Clinical Governance body.
ANIMAL EXPERIMENTS. Twelve- to 14-week-old
wild-type (WT) male BALB/c mice and C57BL/6 mice
were purchased from Harlan Laboratories (Hunting-
don, United Kingdom). DdblGATA mice on a BALB/c
background (8,10) were bred and maintained at the
University of Edinburgh. All animal experiments were
approved by the University of Edinburgh Animal
Welfare and Ethical Review Board and the UK
Home Office.
INFARCT MODEL. MI was induced by permanent
ligation of the left coronary artery in isoflurane
anesthetized mice as previously described (11).
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668Twenty-four hours after surgery, a tail blood sample
was collected for assay of troponin I (Life Diagnostics
High Sensitivity Mouse Cardiac Troponin-I ELISA kit,
Life Diagnostics, West Chester, Pennsylvania) to
assess the extent of myocardial injury.
ANTI-SIGLEC-F ANTISERUM DEPLETION OF EOSINOPHILS.
In the eosinophil depletion study, C57BL/6 mice
received 100 ml of either sheep anti-Siglec-F poly-
clonal antiserum or sheep pre-immune serum (both
gifted by Professor Paul Crocker, University of Dun-
dee, Dundee, United Kingdom) via intraperitoneal
injection at 1 day before and 3 days after MI.
RESCUE EXPERIMENTS IN DdblGATA MICE. Bone
marrow–derived (BMD) eosinophils were adoptively
transferred by intraperitoneal injection into
DdblGATA mice at 1 day before and 3 days after MI.
Purity of >90% for eosinophils was confirmed prior to
intraperitoneal injection by flow cytometric analysis.
For IL-4 replenishment, 5 mg of recombinant mu-
rine IL-4 (PeproTech, Rocky Hill, New Jersey) com-
plexed to 25-mg anti-IL-4 antibody (clone 11B11, Bio X
Cell, Lebanon, New Hampshire) in 100-ml sterile
phosphate-buffered saline (PBS) or 100-ml sterile PBS
was administered to DdblGATA mice via intraperito-
neal injection at day 1 post-MI.
CARDIAC IMAGING. Left ventricular structure and
function was assessed using high-resolution ultra-
sound (VisualSonics Vevo 770, VisualSonics, Toronto,
Canada), under light isoflurane anesthesia, ensuring
that the heart rate was maintained >450 beats/min.
HISTOPATHOLOGY. Eosinophils were detected in
samples of paraffin-embedded infarcted human
myocardium, obtained from the Edinburgh Brain and
Tissue Bank (Supplemental Table 1), using eosinophil
peroxidase antibody (supplied by Elizabeth Jacobsen,
Mayo Clinic, Scottsdale, Arizona).
Paraffin embedded mouse heart sections were
stained with Masson’s trichrome (infarct size) and
picrosirius red (polarized light to collagen fiber status
using polarized light). Angiogenesis was determined
by detection of CD31 immunopositive vessels (rabbit
anti-mouse CD31, 1:50, Abcam, Cambridge, United
Kingdom).
TRANSMISSION ELECTRON MICROSCOPY. Mouse
hearts were fixed in 1% osmium tetroxide in 0.1-M
sodium cacodylate X3 and embedded in TAAB 812
resin (TAAB Laboratories Equipment, Reading,
United Kingdom). Ultrathin sections, 60-nm thick,
were stained in uranyl acetate and lead citrate and
then viewed in a JEOL JEM-1400 Plus transmission
electron microscope (JEOL, Tokyo, Japan).Eosinophils were identified by their typical
morphology with crystalloid granules.
FLOW CYTOMETRY. Immunofluorescence staining
was performed on tail blood samples and single-cell
suspensions from heart digests, pericardial adipose,
spleens, and peritoneal cells. Flow cytometric anal-
ysis was performed on an LSR II instrument (BD Bio-
sciences, Franklin Lakes, New Jersey) and analyzed
using FlowJo software v9.9.4 (Tree Star, Ashland,
Oregon). Infarct zone CD45þCD11bþLy6G-F4/80þ
macrophages were sorted by FACS using a FACS
ARIA II flow cytometer (BD Biosciences). Results
for the heart digests are expressed as cell number
per infarct zone or remote zone, and total counts
were calculated for spleens and the periph-
eral blood.
RNA EXTRACTION AND REAL-TIME QUANTITATIVE
POLYMERASE CHAIN REACTION. RNA was extracted
from infarct zone tissue (RNeasy Mini Kit, Qiagen,
Hilden, Germany) and reverse transcribed to com-
plementary DNA with the QuantiTect Reverse Tran-
scription Kit (Qiagen). Real-time quantitative
polymerase chain reaction (qPCR) was performed
using TAQman gene expression assays (Thermo
Fisher Scientific, Waltham, Massachusetts)
(Supplemental Table 2). Messenger RNA (mRNA)
expression levels were normalized for Rpl32 (house-
keeping gene) expression and are presented as fold
changes. Genes were selected based on prior micro-
array data from the lab (G.A. Gray, unpublished data,
February 2016) that identified them as being signifi-
cantly modified during the early stages of scar
formation, between 3 and 7 days following MI.
TISSUE CYTOKINE ASSAY. Left ventricular infarct
zone tissue was collected 4 days after induction of MI
and snap frozen. Tissue cytokines in the heart protein
extracts were assayed using the mouse Th2 Panel
LEGENDplex assay (BioLegend, San Diego, Califor-
nia), according to the manufacturer’s instructions.
STATISTICS. Continuous variables are expressed as
mean  SEM, unless otherwise stated. The Kolmo-
gorov-Smirnov test was used to test for the normality
of data. Continuous variables with a normal distri-
bution were analyzed using Student’s t-test, or by
analysis of variance. Differences in blood eosinophil
and neutrophil counts between stable angina and
STEMI patients after MI were compared by 1-way
analysis of variance, and multiple comparison was
taken into account using a modified least-squares
difference (Bonferroni) test. Variables with a
nonparametric distribution were analyzed using
Wilcoxon rank sum test or Wilcoxon signed rank test
FIGURE 2 Eosinophils Are Reduced in the Blood and Accumulate in the Heart Following Experimental Myocardial Infarction in Mice
(A) Representative flow cytometry plots showing the gating strategy applied to the left ventricle of wild-type BALB/c mice for detection of neutrophils
(Ne), macrophages (Mo), and eosinophils (Eo). (B) Peripheral blood eosinophil count in BALB/c mice following MI (no MI: n ¼ 12; other time points: n ¼ 5
to 11 per group). (C) Total number of Siglec-FþLy6Gint eosinophils detected by flow cytometry in the infarct and remote zones following MI (no MI: n ¼ 3;
other time points: n ¼ 5 to 6 per group). (D) Representative histogram showing Siglec-F staining of splenic and infarct zone eosinophils at day 4 post-MI.
(E) CD11b and Siglec-F median fluorescence intensity (MFI) of infarct and splenic eosinophils at day 4 post-MI (n ¼ 4 per group). Median values with
25th and 75th percentiles are shown. *p < 0.05, **p < 0.01. Eo ¼ eosinophil; MI ¼ myocardial infarction; Mo ¼ macrophage; Ne ¼ neutrophil.
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670for multiple comparison. Categorical data are pre-
sented as counts and as a percentage. Chi-square tests
was used for comparisons of categorical variables. A p
value <0.05 was considered statistically significant.
All statistical analyses were performed with SPSS 21.0
statistical software package (IBM Corp., Armonk,
New York).
RESULTS
EOSINOPHILS ARE DEPLETED FROM THE BLOOD
AND ACCUMULATE IN THE MYOCARDIUM OF
PATIENTS AFTER ACUTE MI. In 732 patients pre-
senting with STEMI (Supplemental Table 3), blood
eosinophil counts declined over the first 7 to 9 h after
the onset of chest pain and were suppressed
compared with patients with stable angina
(Figure 1A). Peripheral blood neutrophil counts in
STEMI patients remained elevated at a similar level
following the onset of chest pain (Figure 1B), while
there continued to be a decline in eosinophil count
over the same time period. Histological staining of 4
human postmortem hearts (Figures 1C to 1E), collected
from patients who died within 24 h of MI
(Supplemental Table 3), revealed the presence of
eosinophil peroxidase immunopositive eosinophils
within the infarct area, although the distribution was
sparse in comparison with neutrophils identified in
the same tissue (Figures 1E and 1F).
EOSINOPHILS ARE ACTIVATED FOLLOWING
EXPERIMENTAL MI AND ACCUMULATE IN THE
INFARCTED LEFT VENTRICLE. To permit further
interrogation of the role of eosinophils in the heart
following MI, eosinophil numbers in the blood and
heart were also investigated in an experimental
mouse model of MI following coronary artery ligation.
Flow cytometric evaluation of Siglec-Fþ eosinophils
in blood and single-cell digests of the left ventricle
(Figure 2A) revealed that, in parallel with clinical ob-
servations, there was a peripheral blood eosinopenia
after experimental MI (p ¼ 0.005) (Figure 2B). In
keeping with previous studies (12), Siglec-FþLy6Gint
eosinophils were rarely found in uninjured hearts
(Figure 2C). However, eosinophils were recruited to
the heart from day 1 post-MI, and particularly to the
infarct zone, where their numbers peaked at day 4
post-MI, during infarct repair (Figure 2C). Activation
of recruited eosinophils was confirmed by flow
cytometry that showed a higher intensity of Siglec-F
expression on cells infiltrating the inflamed myocar-
dium relative to naïve eosinophils residing in splenic
lymphoid tissue (Figures 2D and 2E) (13). The presence
of eosinophils in tissue at day 4 was confirmed by
their characteristic morphology on electronmicroscopy, with crystalloid containing granules in
the spleen (Figure 3A) and in the infarcted heart
(Figure 3B). In the infarct, variable granule
morphology (Figure 3B, inset) is consistent with
eosinophil activation, as suggested by flow cytom-
etry. At 4 days after MI, eosinophil numbers peaked
at 2% of CD11b positive cells in the infarct, and as in
the human tissue samples (Figure 1), distribution in
the infarct was relatively sparse. Interestingly, elec-
tron microscopy (Figure 3C) and chromotrope R
staining (Figures 3D and 3E) revealed that eosinophils
could often be identified in the epicardial area. Flow
cytometry also showed accumulation of Siglec-F–
expressing activated eosinophils (Figures 3F and 3G)
in the adjacent pericardial adipose tissue, suggesting
that as a potential route of entry or activity.
INFARCT EXPANSION AND DETRIMENTAL POST-MI
REMODELING ARE ENHANCED FOLLOWING
GENETIC DEPLETION OF EOSINOPHILS. To investi-
gate the role of eosinophils recruited to the heart
following injury, MI was induced in DdblGATA mice
with genetic deficiency of eosinophils (8). In keeping
with previous findings (8), analysis of peripheral
blood showed no significant differences between WT
BALB/c and DdblGATA mice with respect to white
blood cell counts at baseline (Supplemental Figure 1).
Deficiency of Siglec-FþLy6Gint eosinophils in the
infarct and remote zones of the left ventricle, as well
as in the spleen, of DdblGATA mice was confirmed by
flow cytometry (Figure 4A). Left ventricular function
and geometry were similar in DdblGATA and WT
BALB/c mice prior to induction of MI (Supplemental
Table 4). Following the induction of MI, high-reso-
lution ultrasound showed that hearts from DdblGATA
mice were more dilated (increased left ventricular
area; p ¼ 0.021) (Figure 4B, Supplemental Table 5)
and had greater impairment of left ventricular func-
tion than did WT BALB/c mice (left ventricular ejec-
tion fraction; p ¼ 0.038) (Figure 4C). Plasma troponin I
concentration at 24 h post-MI was comparable be-
tween DdblGATA (25.7  4.7 ng/ml) and WT BALB/c
mice (27.0  3.6 ng/ml; p ¼ 0.832), indicating similar
initial myocardial injury. However, by day 7 following
induction of MI, scar size was larger in DdblGATA
mice (Figure 4D). There was no influence of eosino-
phil depletion on the extent of angiogenesis post-MI
(Supplemental Figure 2) or on the proportion of
collagen in the infarct (Figure 4E). However, pic-
rosirius red staining under polarizing light revealed
that the proportion of tightly packed collagen fibers in
the infarct zone, which have yellowish-red birefrin-
gence, was reduced in DdblGATA mice (Figure 4F).
This was associated with an increased preponderance
FIGURE 3 Eosinophils Locate to the Heart Following Experimental MI in Mice, With Particular Accumulation Close to the Epicardium
Transmission electron microscopy (TEM) reveals (A) quiescent eosinophils in spleen, with typical electron dense crystalloid containing
granules (inset) and (B) an eosinophil adjacent to a macrophage in infarct 4 days post-MI, varied granule morphology is consistent with
eosinophil activation (inset). (C) TEM showing an eosinophil close to the epicardial border within the infarct. Chromotrope R staining of fixed
sections show eosinophils located (D) close to the epicardial border and (E) in the pericardial adipose tissue. (F) Flow cytometry of pericardial
adipose tissue collected at 4 days post-MI shows accumulation of eosinophils relative to pericardial adipose from uninfarcted heart (no MI).
CD11b and Siglec-F MFI of pericardial adipose and splenic eosinophils at day 4 post-MI (n ¼ 4 per group). Median values with 25th and 75th
percentiles are shown. *p < 0.05. Abbreviations as in Figure 2.
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FIGURE 4 Genetic Depletion of Eosinophils Results in Enhanced Detrimental Remodeling Post–Myocardial Infarction Accompanied by Alteration of
Collagen Scar Size, Morphology, and Collagen Processing Genes
(A) Representative flow cytometry plots demonstrating (Siglec-FþLy6GintF4/80–) eosinophil deficiency in the heart, spleen, and blood of DdblGATA mice
in comparison with BALB/c mice. (B) End-systolic area and (C) ejection fraction at day 7 following MI in wild-type (WT) BALB/c and DdblGATA mice (n ¼ 8
to 9 per group). (D) Masson’s trichrome–stained sections for assessment of scar size, expressed as a percentage of the left ventricle. (E) Picrosirius red–
stained sections for assessment of the proportion of collagen in the infarct zone. (F) Imaging of picrosirius red–stained collagen fibers in the infarct zone
under polarized light reveals a reduced proportion of collagen fibers in the infarct zone with yellow-red birefringence (n ¼ 7 to 8 per group), the
remaining fibers had green birefringence. (G) Messenger RNA expression levels of genes expressing collagen processing genes procollagen-lysine, 2-
oxoglutarate 5-dioxygenase 2 (Plod2) and lysyl oxidase (Lox); transforming growth factor beta 3 (Tgfb3) that regulates Plod2 expression; and elastin (Eln)
in the infarct zone at day 7 following MI (n ¼ 4 to 5 per group). *p < 0.05; **p < 0.01.
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673of thin collagen fibers, which appear green under
polarized light, in the infarct zone of DdblGATA mice
(Figure 4F). Infarct zone whole tissue qPCR at day 7
(Figure 4G) for genes associated with post-trans-
lational collagen processing showed increased mRNA
expression of procollagen-lysine, 2-oxoglutarate
5-dioxygenase 2 (plod2) (p ¼ 0.009), lysyl hydroxylase 2,
lysyl oxidase (Lox) (p ¼ 0.029), and transforming
growth factor beta 3 (tgfb3) (p ¼ 0.008) in DdblGATA
mice in comparison with WT BALB/c mice. mRNA
expression of elastin (Eln) in the infarct zone of
DdblGATA mice was comparable to that in WT BALB/c
mice. These findings support a role for eosinophils in
collagen scar maturation following MI.
PHARMACOLOGICAL INTERVENTION CONFIRMS
ENHANCEMENT OF DETRIMENTAL REMODELING
FOLLOWING EOSINOPHIL DEPLETION. To confirm
the data obtained with genetic deficiency of eosino-
phils in BALB/c mice, an antibody-mediated approach
was used as an alternative means of depleting eo-
sinophils following MI in C57BL/6 mice (Figure 5A).
Successful depletion of Siglec-FþLy6Gint eosinophils
using anti-Siglec-F antiserum was confirmed by flow
cytometry of single-cell digests of infarcted hearts at
day 4 post-MI (Figure 5B). Depletion of eosinophils
did not affect initial injury induced by MI, as
measured by plasma troponin I concentrations at 24 h
post-MI (Supplemental Table 6). By 7 days after MI,
scar size in tissues tended to be increased in anti-
Siglec-F antiserum–treated mice (Figure 5C)
(p ¼ 0.074), and this was accompanied by adverse
remodeling of the left ventricle. High-resolution ul-
trasound showed that hearts from anti-Siglec-F
antiserum–treated mice were more dilated (Figure 5D)
and had greater impairment of left ventricular func-
tion than did pre-immune serum–treated mice
(Figure 5E and Supplemental Table 6).
Thus, pharmacological depletion of eosinophils in
C57BL/6 mice, that have a distinct inflammation and
repair phenotype compared with BALB/c mice (14),
confirmed the adverse cardiac remodeling phenotype
associated with eosinophil depletion, further sup-
porting a role for eosinophils in post-MI remodeling.
EOSINOPHILS SUPPORT AN ANTI-INFLAMMATORY
ENVIRONMENT IN THE INFARCT ZONE. Anti-inflam-
matory Th2-type cytokines have a key role in the
resolution of inflammation and are elevated in the
infarct zone at day 4 post-MI (15). As eosinophils are
known to support a type 2 immune environment
during tissue repair and regeneration, we next aimed
to investigate the influence of eosinophil depletion
on type 2 immune mediator availability in the infarct.
In keeping with an anti-inflammatory role foreosinophils, enzyme-linked immunosorbent assay
showed that the infarct tissue of DdblGATA mice had
significantly reduced availability of IL-4, IL-5, IL-13,
and IL-10 (Figures 6A to 6C), in comparison with WT
BALB/c mice at day 4 following MI. In contrast,
expression of genes encoding the proinflammatory
mediators IL-18 (Il18), chemokine (C-C motif) ligand 5
(Ccl5), and tumor necrosis factor-a (Tnfa) were all
elevated in the infarct zone of DdblGATA mice
compared with WT BALB/c mice at day 7 post-MI
(Figure 6D). Characterization of myocardial inflam-
matory cell content using flow cytometry (Figure 6E)
showed that the number of infarct zone Ly6GhiLy6Cint
neutrophils was higher in DdblGATA mice at day 4
post-MI, relative to WT BALB/c mice (Figure 6F)
(p ¼ 0.025). Infarct zone whole-tissue qPCR for genes
associated with neutrophil recruitment showed
increased mRNA expression of both chemokine (C-X-
C motif) ligand 1 (Cxcl1) (p ¼ 0.038) and chemokine
(C-X-C motif) ligand 2 (Cxcl2) (p ¼ 0.016) (Figure 6H).
Infarct zone F4/80þ macrophage numbers were also
increased in DdblGATA mice (Figure 6H) (p ¼ 0.019)
following MI. Together, these data demonstrate
impaired resolution of inflammation in the absence
of eosinophils.
DELAYED ACQUISITION OF A PROREPAIR MACROPHAGE
PHENOTYPE IN EOSINOPHIL DEFICIENT MYOCARDIUM IS
RESCUED BY EOSINOPHIL REPLACEMENT. Resolution of
inflammation following MI occurs with a transition
toward an anti-inflammatory macrophage phenotype
that is essential for repair and prevention of adverse
cardiac remodeling (2). CD206 expression is typically
increased on these alternatively activated anti-in-
flammatory macrophages (2). The next aim was
therefore to investigate whether eosinophils were
required for acquisition of a CD206þ anti-inflamma-
tory macrophage phenotype following MI. CD206 was
present on nearly 80% of macrophages in naïve hearts
(Figure 7A). Within the first 24 h after induction of MI,
representation of CD206þ macrophages was reduced
to <20% and F4/80þCD206- proinflammatory macro-
phages dominated in the infarct zone (Figure 7A). On
day 4 post-MI, nearly 40% of infarct zone macro-
phages from WT BALB/c once again expressed CD206
(Figure 7A). However, acquisition of CD206 expres-
sion by infarct zone macrophages was impaired at day
4 post-MI in DdblGATA mice (Figure 7A), supporting
key roles for eosinophils in driving infarct zone
macrophage polarization toward an anti-inflamma-
tory phenotype following MI. Expression of the
mRNA encoding the anti-inflammatory macrophage
marker, resistin-like molecule a (Retnla/RELMa), was
also reduced in macrophages sorted from the infarct
FIGURE 5 Pharmacologic Depletion of Eosinophils Reproduces Adverse Remodeling in C57BL/6 Mice
(A) C57BL/6 mice were treated with anti-Siglec-F anti-serum 1 day before and 3 days after induction of myocardial infarction (MI). (B) Flow
cytometry reveals successful depletion of Siglec-FþLy6Gint eosinophils within the infarcted heart following antiserum treatment. (C) Scar
size, (D) end-systolic area, and (E) ejection fraction at day 7 following MI in pre-immune serum–treated (n ¼ 6) and anti-Siglec-F anti-serum–
treated C57BL/6 mice (n ¼ 6). *p < 0.05, **p < 0.01. i.p. ¼ intraperitoneal.
Toor et al. J A C C : B A S I C T O T R A N S L A T I O N A L S C I E N C E V O L . 5 , N O . 7 , 2 0 2 0
Myocardium in Atrial Fibrillation J U L Y 2 0 2 0 : 6 6 5 – 8 1
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mice (Figure 7B) (n ¼ 4 to 8 per group).
To confirm that loss of macrophage polarization
during infarct repair was due to eosinophildeficiency, BMD eosinophils were adoptively trans-
ferred by intraperitoneal injection into DdblGATA
mice before and after MI (Figure 7C). Adoptive trans-
fer of BMD eosinophils resulted in restoration of
FIGURE 6 Eosinophils Are Required for Acquisition of an Anti-Inflammatory Th2-Dominant Environment During Infarct Repair. Enzyme-
Linked Immunosorbent Assay Reveals Reduced Availability of Th2 Cytokines
Continued on the next page
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676CD206 expression on infarct zone macrophages from
DdblGATA mice to levels of those from WT BALB/c
mice (Figures 7D and 7E).
ADVERSE CARDIAC REMODELING ASSOCIATED
WITH EOSINOPHIL DEFICIENCY IS RESCUED BY
THERAPEUTIC IL-4 COMPLEX. As type 2 cytokine
availability is reduced in the setting of eosinophil
deficiency in DdblGATA mice, it was reasoned that
therapeutic application of IL-4 might be an effective
means to rescue adverse remodeling. A long-acting
IL-4 complex was therefore administered to
DdblGATA and WT BALB/c mice 24 h after induction
of MI (Figure 8A). Plasma troponin I concentrations at
24 h post-MI were comparable between WT BALB/c
and DdblGATA mice prior to treatment with either
PBS or IL-4 complex (Supplemental Tables 7 and 8),
indicating similar initial injury in all groups. High-
resolution ultrasound showed that while IL-4
complex had no impact on remodeling in eosinophil-
replete WT BALB/c mice when given 24 h after injury
(Figures 8B and 8C and Supplemental Table 7), it was
able to rescue the adverse remodeling phenotype in
eosinophil-deficient DdblGATA mice (Figures 8D and
8E and Supplemental Table 8).
DISCUSSION
Blood eosinophil count is reduced in the acute period
following MI, and we have previously shown that low
peripheral blood eosinophil count predicts adverse
outcome (5). Analysis of human myocardium
collected postmortem following MI identified eosin-
ophils, suggesting that they are recruited to the site of
injury, consistent with previous identification of eo-
sinophils in postmortem myocardium collected
following MI (16). However, distribution was rela-
tively sparse in the infarct, and this clinical observa-
tion leaves open the question of whether eosinophil
recruitment to the injured heart has any negative orFIGURE 6 Continued
(A) Interleukin (IL)-4, (B) IL-5 and IL-13, and (C) IL-10 in the infarct zones
MI (n ¼ 9 per group; median values with 25th and 75th percentiles are
proinflammatory IL-1b (Il1b), IL-6 (Il6), IL-18 (Il18), interferon-g (Ifng), tu
the infarct zone at day 7 following MI (n ¼ 4 to 6 per group; median va
levels were normalized for Rpl32 (housekeeping gene) expression. (E) R
applied to the infarct zone tissue of wild-type (WT) BALB/c and DdblGAT
(F) Total number of neutrophils in the uninfarcted heart (no-MI) and in
chemokine (C-X-C motif) ligand 1 (Cxcl1) and chemokine (C-X-C motif) lig
mRNA expression levels were normalized for Rpl32 (housekeeping gene
uninfarcted heart (no MI) and in the infarct zone 4 days after MI (no MI: n
Abbreviations as in Figure 2.positive influence on subsequent repair and remod-
eling. Eosinophil recruitment has previously been
linked to promotion of detrimental remodeling in
chronic heart failure (17). In addition, it cannot be
excluded that death may have influenced eosinophil
recruitment to the infarct zone in postmortem sam-
ples. To address these questions, the role of eosino-
phils was investigated further using an experimental
model of MI in the mouse that permits manipulation
of eosinophil availability.
EOSINOPHILS ARE RECRUITED TO THE HEART AND
ACTIVATED FOLLOWING EXPERIMENTAL MI. In the
mouse model, eosinophil numbers in the peripheral
blood also declined after MI, and this was associated
with accumulation of eosinophils in the myocardium
that began within 24 h and continued to increase to a
peak at 4 days after MI. The temporal mismatch be-
tween the decline of eosinophil numbers in the blood
and accumulation in the tissue indicates a more
complex regulation of peripheral blood eosinophils
than can be accounted for simply by recruitment to
tissue. Inflammatory cytokines produced by activated
innate immune cells (18) and stress responses,
mediated by adrenal corticosteroids (19), can lead to
eosinophil apoptosis and contribute to a decline in
peripheral blood eosinophil count. Clarifying how the
inflammatory environment following MI influences
eosinophil survival during the period of eosinophil
recruitment to the infarct zone will in the future
provide clues to better understand the association of
peripheral blood eosinophil count with outcome in MI
patients (5–7).
Recruitment of eosinophils to the repairing mouse
myocardium, reproducing the clinical observation, is
consistent with an active role for eosinophils
following MI. This is further supported by the obser-
vation that on becoming resident in the infarcted
heart, alteration of granule morphology (4,13) is
accompanied by increased expression of Siglec-F,of DdblGATA compared with wild-type (WT) mice at day 4 following
shown); and (D) increased messenger RNA (mRNA) expression of
mor necrosis factor-a (Tnfa), chemokine (C-C motif) ligand 5 (Ccl5) in
lues with 25th and 75th percentiles are shown). mRNA expression
epresentative flow cytometry plots showing the gating strategy
A mice for detection of neutrophils, macrophages, and eosinophils.
the infarct zone 4 days after MI. (G) mRNA expression levels of
and 2 (Cxcl2) in the infarct zone following MI (n ¼ 4 to 6 per group).
) expression. (H) Total number of F4/80þ macrophages in the
¼ 3; day 4 post-MI: n ¼ 7 to 10 per group). *p < 0.05, **p < 0.01.
FIGURE 7 Delayed Acquisition of a Prorepair Macrophage Phenotype in Eosinophil-Deficient Myocardium Is Rescued by Eosinophil Replacement
(A) The proportion of CD206-expressing F4/80þ macrophages in unoperated hearts (no myocardial infarction [MI]) and in the infarct zone at days 1 and 4
post-MI in DdblGATA compared with wild-type (WT) BALB/c mice (no MI: n ¼ 3; other time points: n ¼ 4 to 10 per group; median values with 25th and
75th percentiles are shown). (B)Messenger RNA (mRNA) expression levels of chitinase-like 3 (Ym1), macrophage mannose receptor (Mmr), and resistin-like
molecule a (Relma) in macrophages sorted from the infarct zone at day 7 following MI (n ¼ 4 to 8 per group). (C) Protocol for delivery of bone marrow–
derived (BMD) eosinophils, or phosphate-buffered saline (PBS), 1 day before and 3 days after MI. (D) Representative histogram of CD206-expressing
F4/80þ macrophages in the infarct zones of PBS-treated or BMD eosinophil–replenished DdblGATA mice at day 4 post-MI. (E) Proportion of
CD206-expressing F4/80þ macrophages in the infarct and remote zones of PBS-treated or BMD eosinophil–replenished DdblGATA mice at day 4 post-MI
(n ¼ 5 to 7 per group). *p < 0.05. i.p. ¼ intraperitoneal.
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FIGURE 8 IL-4 Therapy Rescues the Excess Adverse Remodeling Phenotype in Eosinophil-Deficient DdblGATA Mice
Continued on the next page
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679indicating a switch from a homeostatic to an activated
phenotype (13,20). Overall, eosinophil recruitment
appeared to be low in the heart relative to other
CD11bþ cells, suggesting that interaction with neigh-
boring cells may be required to amplify their influ-
ence in infarct repair. Identification of eosinophils in
the pericardial adipose and near to the epicardium is
interesting, particularly given the recent identifica-
tion of key roles for cells at these sites in determi-
nation of inflammation, scar formation, and cardiac
function after MI (21–24). The potential for in-
teractions of eosinophils at these sites merits further
investigation.
EOSINOPHIL DEPLETION RESULTS IN ADVERSE
REMODELING ASSOCIATED WITH IMPAIRED SCAR
FORMATION. A functional role for eosinophils was
confirmed in vivo in eosinophil-deficient DdblGATA
BALB/c mice (8), and also in C57BL/6 mice with
antibody-mediated eosinophil depletion with anti-
Siglec-F antiserum (13). Both models of eosinophil
depletion were accompanied by an increase in
adverse structural and functional remodeling, indi-
cating that, despite their low representation relative
to neutrophil and macrophages, eosinophils have a
key positive impact on myocardial repair and
remodeling following their recruitment from the
blood. Importantly, this outcome was clear in mice
that are more (BALB/c) or less (C57BL/6) skewed to-
ward Th2 immune dominance (14), showing that the
influence of eosinophils is not dependent on mouse
strain or immune phenotype. Adverse remodeling
was accompanied by an increase in scar size in the
myocardium of DdblGATA mice relative to WT,
despite no difference in the initial ischemia-induced
injury. Angiogenesis was unchanged in eosinophil-
deficient mice, suggesting that infarct expansion did
not occur due to reduced blood supply in the infarct
border. Formation of a stable collagen scar is key for
determination of wall stress, infarct expansion, and
subsequent ventricular remodeling following MI.
There was no indication that the amount of collagen,
revealed by picrosirius red staining, was different
between samples. However, investigation of the
infarct scar using birefringence microscopy revealed
modification of collagen fibril formation in eosino-
phil-deficient mice. Eosinophil depletion also resul-
ted in increased infarct zone expression of plod2,FIGURE 8 Continued
(A) Protocol for administration of IL-4 complex 1 day after induction of
injected i.p. with PBS or IL-4 complex (n ¼ 5 to 9 per group). (D) End-sy
injected i.p. with PBS or IL-4 complex. *p < 0.05; **p < 0.01. Abbreviaencoding lysyl hydroxylase 2 (LH2), and also tgfb3,
encoding transforming growth factor beta 3 (TGF-b3),
which upregulates plod2 expression in fibroblasts
(25). Increased plod2 expression leads to increased
post-translational collagen crosslinking, resulting in
reduced tensile strength (26–28). The detrimental
effects of increased collagen crosslinking have been
identified in the weakened aortic wall present in
Marfan syndrome and abdominal aortic aneurysms
(28). Therefore, disrupted post-translational collagen
processing in the infarct zone may underlie infarct
expansion and ventricular dilatation observed
following MI in the absence of eosinophils. Evidence
is now accumulating that epicardial fibroblasts have a
key role in the formation of infarct scar (21,23).
Identification of eosinophils in the epicardium pre-
sents the intriguing possibility that they might influ-
ence fibroblast phenotype either directly or
indirectly, via interaction with other cells, at
this location.
EOSINOPHILS ARE REQUIRED TO PROMOTE RESOLUTION
OF INFLAMMATION DURING POST-INFARCT REPAIR.
Inflammation is essential for infarct repair but when
excessive or prolonged is associated with adverse
cardiac remodeling (29). In other settings, eosinophil-
derived proresolving lipid mediators can reduce the
numbers of neutrophils in inflamed tissue (3,4) by
counter-regulating neutrophil influx and stimulating
macrophage phagocytosis of apoptotic neutrophils
(5), thus promoting the resolution of inflammation.
Neutrophil recruitment to the heart following MI was
increased in eosinophil-deficient DdblGATA mice,
and this was associated with increased expression of
proinflammatory mediators, including neutrophil-
recruiting chemokines. Eosinophil-deficient
DdblGATA mice also had reduced availability of the
anti-inflammatory Th2-type cytokines, IL-4, IL-5, IL-
13, and IL-10, in the infarct tissue. This was accom-
panied by a reduction in the proportion of infarct
zone macrophages expressing CD206þ and RELM-a,
that identify anti-inflammatory, proresolution, and
prorepair macrophage phenotypes in the infarct zone
(2). Following MI, CD206þ macrophages produce
paracrine mediators that activate cardiac fibroblasts
promoting scar formation (2). Consistent with our
data, Qin et al. (30) have recently demonstrated
increased expression of CD206 and RELM-a whenMI. (B) End-systolic area and (C) ejection fraction at day 7 following MI in WT BALB/c mice
stolic area and (E) ejection fraction at day 7 following MI (n ¼ 7 per group) in DdblGATA mice
tions as in Figure 7.
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE:
Formation of a stable scar and resolution of inflam-
mation are central features of successful infarct repair
following myocardial infarction. Eosinophils appear to
have a key role in these processes.
TRANSLATIONAL OUTLOOK: Further studies are
needed to evaluate prospectively the prognostic
predictive value of a low peripheral blood eosinophil
count and the potential therapeutic efficacy of IL-4 in
preventing adverse cardiac remodeling in patients
following myocardial infarction.
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680cultured macrophages were treated with human
eosinophil–conditioned media. In the current study,
loss of CD206þ macrophages in the infarct of eosino-
phil-deficient DdblGATA mice was rescued by eosin-
ophil replenishment. Recent single-cell sequencing
studies have provided new evidence for the
complexity of macrophage phenotypes found in the
myocardium (31), with varied potential roles in
determining resolution of inflammation, repair, and
remodeling (32). Collectively, the findings presented
here support a role for eosinophils in driving transi-
tion to resolution of inflammation and stable scar
formation during infarct repair. Further studies will
be required to identify the impact of eosinophil
depletion on the distribution of specific macro-
phage phenotypes.
THERAPEUTIC IL-4 RESCUES ADVERSE POST-MI IN
THE SETTING OF EOSINOPHIL DEFICIENCY. IL-4–
mediated activation of macrophages is known to
induce characteristic expression of specific effector
molecules (e.g., RELM-a) and is associated with the
adoption of a wound healing phenotype (33). Previ-
ous experiments have demonstrated the importance
of this phenotype during post-MI repair (2) and the
ability of therapeutic IL-4 to enhance accumulation of
CD206þ “wound-healing” macrophages and prevent
detrimental remodeling, at least when administered
immediately after injury (3). Eosinophils are a key
source of IL-4, and indeed other molecules, in
noncardiac tissue repair and regeneration (20,34,35).
Experiments in eosinophil-deficient mice showed
that IL-4 availability in the infarct was significantly
reduced at day 4 following MI, the time point at
which eosinophil recruitment to the myocardium
peaks, and also a key time point for transition of
macrophages from an inflammatory to a repair
phenotype (36). Given the relative sparsity of
recruited eosinophils in the heart after MI, it seems
unlikely that they are the primary source of IL-4 here;
however, they might influence the formation of IL-4
and other cytokines by neighboring cells in the infarct
milieu. Interestingly, administration of IL-4 complex
24 h after MI, when eosinophil recruitment to the
myocardium is already significantly increased, had no
influence on post-MI remodeling in eosinophil-
replete mice. This is consistent with the previous
studies that showed therapeutic benefit of IL-4 only
when given prior to (2) or immediately after (3) MI.
However, IL-4 complex administration was effective
in reversing adverse cardiac remodeling in eosino-
phil-deficient mice. This positive outcome could
result from direct replacement of IL-4 missing in
eosinophil-deficient mice or perhaps from activationby therapeutic IL-4 of proresolution and prorepair
mechanisms that are able to overcome the combined
effects of eosinophil depletion.
In summary, this study identifies eosinophils as
key effector cells of the type 2 innate immune
response required for acute post-MI cardiac repair.
IL-4 therapy, already proposed as a means to improve
outcomes post-MI (3), was effective in reversing
detrimental outcomes in the setting of eosinophil
deficiency in experimental MI. The use of biomarkers
such as a persistently low peripheral blood eosinophil
count post-MI may therefore provide a means to
direct IL-4 therapy to patients who might gain the
most benefit from it.
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